By Femtech Insider Biotech, Fertility, News, Reproductive Health August 22, 2022 ShareTwitterFacebookPinterest-circled ART: Japanese Fertility Startup Dioseve Raises $3M to Re-engineer Oocyte Development
By Femtech Insider Biotech, Investment, News, Women's Health August 11, 2022 ShareTwitterFacebookPinterest-circled Nanopath Raises $10M in Series A Funding to Develop and Commercialize Point-of-Care Diagnostics for Women’s Health
By Femtech Insider Biotech, News, Pharma, Women's Health June 14, 2022 ShareTwitterFacebookPinterest-circled Organon Signs a Licensing Deal with Henlius for Biosimilars Targeting Osteoporosis and Breast Cancer
By Femtech Insider Biotech, Hormonal Health, Investment, Menopause, News May 20, 2022 ShareTwitterFacebookPinterest-circled Women’s Health Biotech Company Oviva Raises $11.5M in Seed Funding to Address Ovarian Aging
By Femtech Insider Biotech, Maternal Health, News, Pregnancy May 18, 2022 ShareTwitterFacebookPinterest-circled Biotech Company Mirvie Raises $60M for Its RNA Platform Focused on Early Prediction of Pregnancy Complications
By Femtech Insider Biotech, Cancer, Menopause, News May 16, 2022 ShareTwitterFacebookPinterest-circled Celmatix Reaches a Key Preclinical Milestone in Its Premature Menopause Prevention Drug Program
By Femtech Insider Biotech, News, Pregnancy February 21, 2022 ShareTwitterFacebookPinterest-circled Renegade.bio and Metabolomic Diagnostics Partner to Develop a Novel Preeclampsia Risk Screening Test
By Femtech Insider Biotech, Menopause, News January 24, 2022 ShareTwitterFacebookPinterest-circled Biotech Company Amyris Gets Serious about the Menopause Market with the Acquisition of Menolabs
